[1]
2024. Effects of SGLT2 inhibitors on hemoglobin levels in patients with chronic kidney disease: A bibliographic review. Revista Médica de Trujillo. 19, 3 (Sep. 2024), 098–102. DOI:https://doi.org/10.17268/rmt.2024.v19i3.6142.